ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025
Published Date: November 2025
|
Report Code: QYRE-Auto-12S20176
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025
BUY CHAPTERS

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

Code: QYRE-Auto-12S20176
Report
November 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Eisal
Idorsia Ltd
Simcere Pharmaceutical
Nxera Pharma

Dual Orexin Receptor Antagonist Sleeping Pills Market Size

The global market for Dual Orexin Receptor Antagonist Sleeping Pills was valued at US$ 671 million in the year 2024 and is projected to reach a revised size of US$ 1235 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Dual Orexin Receptor Antagonist Sleeping Pills Market

Dual Orexin Receptor Antagonist Sleeping Pills Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dual Orexin Receptor Antagonist Sleeping Pills competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Dual Orexin Receptor Antagonist (DORA) sleeping pills are a class of innovative central nervous system drugs that promote sleep by blocking the activity of orexin receptors (Orexin-1R and Orexin-2R) in the hypothalamus. By inhibiting the transmission of wake-promoting signals, these agents help patients fall asleep naturally and maintain sleep without significantly affecting sleep architecture. Representative drugs include Daridorexant, Suvorexant, and Lemborexant. The upstream raw materials primarily consist of pharmaceutical-grade organic intermediates, heterocyclic compounds, and pyridine and imidazole derivatives. Core suppliers include Idorsia’s raw material production facilities in Switzerland, Sumitomo Chemical (Japan), BASF (Germany), Mitsubishi Chemical (Japan), and leading Chinese companies such as WuXi AppTec and Asymchem, together forming a globalized network for raw material and formulation supply.
Dual Orexin Receptor Antagonists (DORAs) represent a new generation of sleep-promoting medications with distinct advantages over traditional benzodiazepine, non-benzodiazepine, or melatonin receptor agonist hypnotics. By selectively blocking orexin-mediated wakefulness pathways, DORAs induce sleep in a physiologically natural manner without suppressing the central nervous system or altering normal sleep architecture. They provide restorative sleep with minimal next-day sedation, low potential for dependence or withdrawal, and favorable long-term safety. Moreover, DORAs do not significantly impair cognition, motor coordination, or memory, making them suitable for chronic insomnia patients, including those with comorbid anxiety or depression, and marking a paradigm shift in sleep medicine toward neuroregulatory mechanisms rather than sedation.
In 2024, global sales of Dual Orexin Receptor Antagonist sleeping pills reached 4,219,182 boxes, with a production capacity of 6,000,000 boxes. The average unit price was USD 159 per box, and the average corporate gross profit margin ranged between 60% and 70%.
Regional Market Structure
In the global market for Dual Orexin Receptor Antagonist sleeping drugs, North America accounts for 46%, Europe for 28%, Asia-Pacific for 21%, and other regions for 5%. North America maintains its leading position driven by a high prevalence of insomnia, mature prescription systems, and comprehensive insurance coverage. Europe demonstrates stable growth supported by regulatory relaxation and improved patient awareness, while the Asia-Pacific region—particularly China, Japan, and South Korea—is emerging as a new growth engine with faster registration and market access. Other regions, though smaller in scale, show increasing potential and diversified development momentum.
Technology Trends and Innovation Directions
Technological progress centers on molecular optimization to enhance receptor selectivity and metabolic stability, with drug design evolving toward shorter half-lives and higher efficacy-to-safety ratios to minimize residual sedation. Formulation technology is advancing toward orally disintegrating tablets, sustained-release preparations, and combination therapies to address diverse patient needs. Digitalization and artificial intelligence are increasingly applied in compound screening, clinical trial design, and personalized therapy, marking a shift in sleep medicine from traditional sedation to precision neuroregulation.
Policy and Industry Development Drivers
Rising global demand for insomnia treatment, stronger mental health policies, and innovation incentives are the key industry drivers. In Western markets, accelerated approval pathways and market exclusivity provisions support rapid commercialization of novel drugs, while in Asia, consistency evaluation and localization policies enhance generic drug competitiveness. Regulators are imposing stricter requirements on long-term safety and dependency risk, prompting companies to strengthen clinical evidence accumulation. Expansion of healthcare coverage and growing public awareness of sleep health together form the foundation for sustainable industry growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dual Orexin Receptor Antagonist Sleeping Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dual Orexin Receptor Antagonist Sleeping Pills.
The Dual Orexin Receptor Antagonist Sleeping Pills market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dual Orexin Receptor Antagonist Sleeping Pills market comprehensively. Regional market sizes, concerning products by Type, by Application, by Dosage Form and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dual Orexin Receptor Antagonist Sleeping Pills manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Dosage Form and by regions.

Scope of Dual Orexin Receptor Antagonist Sleeping Pills Market Report

Report Metric Details
Report Name Dual Orexin Receptor Antagonist Sleeping Pills Market
Accounted market size in year US$ 671 million
Forecasted market size in 2031 US$ 1235 million
CAGR 7.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Suvorexant
  • Lemborexant
  • Daridorexant
Segment by Dosage Form
  • Tablets
  • Other
Segment by Research Attributes
  • Original Drug
  • Generic Drug
Segment by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Eisal, Idorsia, Simcere Pharmaceutical, Nxera Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dual Orexin Receptor Antagonist Sleeping Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dual Orexin Receptor Antagonist Sleeping Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Dual Orexin Receptor Antagonist Sleeping Pills Market growing?

Ans: The Dual Orexin Receptor Antagonist Sleeping Pills Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Dual Orexin Receptor Antagonist Sleeping Pills Market size in 2031?

Ans: The Dual Orexin Receptor Antagonist Sleeping Pills Market size in 2031 will be US$ 1235 million.

What is the Dual Orexin Receptor Antagonist Sleeping Pills Market share by region?

Ans: In the global market for Dual Orexin Receptor Antagonist sleeping drugs, North America accounts for 46%, Europe for 28%, Asia-Pacific for 21%, and other regions for 5%.

Who are the main players in the Dual Orexin Receptor Antagonist Sleeping Pills Market report?

Ans: The main players in the Dual Orexin Receptor Antagonist Sleeping Pills Market are Merck, Eisal, Idorsia, Simcere Pharmaceutical, Nxera Pharma

What are the Application segmentation covered in the Dual Orexin Receptor Antagonist Sleeping Pills Market report?

Ans: The Applications covered in the Dual Orexin Receptor Antagonist Sleeping Pills Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Dual Orexin Receptor Antagonist Sleeping Pills Market report?

Ans: The Types covered in the Dual Orexin Receptor Antagonist Sleeping Pills Market report are Suvorexant, Lemborexant, Daridorexant

1 Dual Orexin Receptor Antagonist Sleeping Pills Market Overview
1.1 Product Definition
1.2 Dual Orexin Receptor Antagonist Sleeping Pills by Type
1.2.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value Comparison by Type (2024 VS 2031)
1.2.2 Suvorexant
1.2.3 Lemborexant
1.2.4 Daridorexant
1.3 Dual Orexin Receptor Antagonist Sleeping Pills by Dosage Form
1.3.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value Comparison by Dosage Form: 2024 VS 2031
1.3.2 Tablets
1.3.3 Other
1.4 Dual Orexin Receptor Antagonist Sleeping Pills by Research Attributes
1.4.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value Comparison by Research Attributes: 2024 VS 2031
1.4.2 Original Drug
1.4.3 Generic Drug
1.5 Dual Orexin Receptor Antagonist Sleeping Pills by Application
1.5.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value by Application (2024 VS 2031)
1.5.2 Hospital and Clinic
1.5.3 Retail Pharmacies
1.5.4 Other
1.6 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Size Estimates and Forecasts
1.6.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue 2020-2031
1.6.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales 2020-2031
1.6.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Dual Orexin Receptor Antagonist Sleeping Pills Market Competition by Manufacturers
2.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dual Orexin Receptor Antagonist Sleeping Pills, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dual Orexin Receptor Antagonist Sleeping Pills, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dual Orexin Receptor Antagonist Sleeping Pills, Product Type & Application
2.7 Global Key Manufacturers of Dual Orexin Receptor Antagonist Sleeping Pills, Date of Enter into This Industry
2.8 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Competitive Situation and Trends
2.8.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dual Orexin Receptor Antagonist Sleeping Pills Players Market Share by Revenue
2.8.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Scenario by Region
3.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region: 2020-2031
3.2.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region: 2020-2025
3.2.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region: 2026-2031
3.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region: 2020-2031
3.3.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region: 2020-2025
3.3.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region: 2026-2031
3.4 North America Dual Orexin Receptor Antagonist Sleeping Pills Market Facts & Figures by Country
3.4.1 North America Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2020-2031)
3.4.3 North America Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dual Orexin Receptor Antagonist Sleeping Pills Market Facts & Figures by Country
3.5.1 Europe Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2020-2031)
3.5.3 Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Market Facts & Figures by Region
3.6.1 Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region (2020-2031)
3.6.3 Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dual Orexin Receptor Antagonist Sleeping Pills Market Facts & Figures by Country
3.7.1 Latin America Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2020-2031)
3.7.3 Latin America Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2020-2031)
4.1.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2020-2025)
4.1.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2026-2031)
4.1.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2020-2031)
4.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Type (2020-2031)
4.2.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Type (2020-2025)
4.2.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Type (2026-2031)
4.2.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Type (2020-2031)
4.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2020-2031)
5.1.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2020-2025)
5.1.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2026-2031)
5.1.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Application (2020-2031)
5.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Application (2020-2031)
5.2.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Application (2020-2025)
5.2.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Application (2026-2031)
5.2.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Application (2020-2031)
5.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Eisal
6.2.1 Eisal Company Information
6.2.2 Eisal Description and Business Overview
6.2.3 Eisal Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eisal Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolio
6.2.5 Eisal Recent Developments/Updates
6.3 Idorsia
6.3.1 Idorsia Company Information
6.3.2 Idorsia Description and Business Overview
6.3.3 Idorsia Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Idorsia Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolio
6.3.5 Idorsia Recent Developments/Updates
6.4 Simcere Pharmaceutical
6.4.1 Simcere Pharmaceutical Company Information
6.4.2 Simcere Pharmaceutical Description and Business Overview
6.4.3 Simcere Pharmaceutical Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Simcere Pharmaceutical Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolio
6.4.5 Simcere Pharmaceutical Recent Developments/Updates
6.5 Nxera Pharma
6.5.1 Nxera Pharma Company Information
6.5.2 Nxera Pharma Description and Business Overview
6.5.3 Nxera Pharma Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nxera Pharma Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolio
6.5.5 Nxera Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dual Orexin Receptor Antagonist Sleeping Pills Industry Chain Analysis
7.2 Dual Orexin Receptor Antagonist Sleeping Pills Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dual Orexin Receptor Antagonist Sleeping Pills Production Mode & Process Analysis
7.4 Dual Orexin Receptor Antagonist Sleeping Pills Sales and Marketing
7.4.1 Dual Orexin Receptor Antagonist Sleeping Pills Sales Channels
7.4.2 Dual Orexin Receptor Antagonist Sleeping Pills Distributors
7.5 Dual Orexin Receptor Antagonist Sleeping Pills Customer Analysis
8 Dual Orexin Receptor Antagonist Sleeping Pills Market Dynamics
8.1 Dual Orexin Receptor Antagonist Sleeping Pills Industry Trends
8.2 Dual Orexin Receptor Antagonist Sleeping Pills Market Drivers
8.3 Dual Orexin Receptor Antagonist Sleeping Pills Market Challenges
8.4 Dual Orexin Receptor Antagonist Sleeping Pills Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Eisal
Idorsia Ltd
Simcere Pharmaceutical
Nxera Pharma
List of Tables
 Table 1. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value by Dosage Form, (US$ Million) & (2024 VS 2031)
 Table 3. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value by Research Attributes, (US$ Million) & (2024 VS 2031)
 Table 4. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 5. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Competitive Situation by Manufacturers in 2024
 Table 6. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units) of Key Manufacturers (2020-2025)
 Table 7. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Manufacturers (2020-2025)
 Table 8. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 9. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Share by Manufacturers (2020-2025)
 Table 10. Global Market Dual Orexin Receptor Antagonist Sleeping Pills Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 11. Global Key Players of Dual Orexin Receptor Antagonist Sleeping Pills, Industry Ranking, 2022 VS 2023 VS 2024
 Table 12. Global Key Manufacturers of Dual Orexin Receptor Antagonist Sleeping Pills, Manufacturing Sites & Headquarters
 Table 13. Global Key Manufacturers of Dual Orexin Receptor Antagonist Sleeping Pills, Product Type & Application
 Table 14. Global Key Manufacturers of Dual Orexin Receptor Antagonist Sleeping Pills, Date of Enter into This Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Dual Orexin Receptor Antagonist Sleeping Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dual Orexin Receptor Antagonist Sleeping Pills as of 2024)
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 19. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region (2020-2025) & (K Units)
 Table 20. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Region (2020-2025)
 Table 21. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region (2026-2031) & (K Units)
 Table 22. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Region (2026-2031)
 Table 23. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region (2020-2025) & (US$ Million)
 Table 24. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Region (2020-2025)
 Table 25. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region (2026-2031) & (US$ Million)
 Table 26. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Region (2026-2031)
 Table 27. North America Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. North America Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2020-2025) & (K Units)
 Table 29. North America Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2026-2031) & (K Units)
 Table 30. North America Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2020-2025) & (US$ Million)
 Table 31. North America Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2026-2031) & (US$ Million)
 Table 32. Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 33. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2020-2025) & (K Units)
 Table 34. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2026-2031) & (K Units)
 Table 35. Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2020-2025) & (US$ Million)
 Table 36. Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2026-2031) & (US$ Million)
 Table 37. Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 38. Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region (2020-2025) & (K Units)
 Table 39. Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region (2026-2031) & (K Units)
 Table 40. Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region (2020-2025) & (US$ Million)
 Table 41. Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Latin America Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2020-2025) & (K Units)
 Table 44. Latin America Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2026-2031) & (K Units)
 Table 45. Latin America Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2026-2031) & (US$ Million)
 Table 47. Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 48. Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2020-2025) & (K Units)
 Table 49. Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2026-2031) & (K Units)
 Table 50. Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2020-2025) & (US$ Million)
 Table 51. Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2026-2031) & (US$ Million)
 Table 52. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units) by Type (2020-2025)
 Table 53. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units) by Type (2026-2031)
 Table 54. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2020-2025)
 Table 55. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2026-2031)
 Table 56. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue (US$ Million) by Type (2020-2025)
 Table 57. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue (US$ Million) by Type (2026-2031)
 Table 58. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Type (2020-2025)
 Table 59. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Type (2026-2031)
 Table 60. Global Dual Orexin Receptor Antagonist Sleeping Pills Price (US$/Unit) by Type (2020-2025)
 Table 61. Global Dual Orexin Receptor Antagonist Sleeping Pills Price (US$/Unit) by Type (2026-2031)
 Table 62. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units) by Application (2020-2025)
 Table 63. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units) by Application (2026-2031)
 Table 64. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Application (2020-2025)
 Table 65. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Application (2026-2031)
 Table 66. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue (US$ Million) by Application (2020-2025)
 Table 67. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue (US$ Million) by Application (2026-2031)
 Table 68. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Application (2020-2025)
 Table 69. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Application (2026-2031)
 Table 70. Global Dual Orexin Receptor Antagonist Sleeping Pills Price (US$/Unit) by Application (2020-2025)
 Table 71. Global Dual Orexin Receptor Antagonist Sleeping Pills Price (US$/Unit) by Application (2026-2031)
 Table 72. Merck Company Information
 Table 73. Merck Description and Business Overview
 Table 74. Merck Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Merck Dual Orexin Receptor Antagonist Sleeping Pills Product
 Table 76. Merck Recent Developments/Updates
 Table 77. Eisal Company Information
 Table 78. Eisal Description and Business Overview
 Table 79. Eisal Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Eisal Dual Orexin Receptor Antagonist Sleeping Pills Product
 Table 81. Eisal Recent Developments/Updates
 Table 82. Idorsia Company Information
 Table 83. Idorsia Description and Business Overview
 Table 84. Idorsia Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Idorsia Dual Orexin Receptor Antagonist Sleeping Pills Product
 Table 86. Idorsia Recent Developments/Updates
 Table 87. Simcere Pharmaceutical Company Information
 Table 88. Simcere Pharmaceutical Description and Business Overview
 Table 89. Simcere Pharmaceutical Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Simcere Pharmaceutical Dual Orexin Receptor Antagonist Sleeping Pills Product
 Table 91. Simcere Pharmaceutical Recent Developments/Updates
 Table 92. Nxera Pharma Company Information
 Table 93. Nxera Pharma Description and Business Overview
 Table 94. Nxera Pharma Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Nxera Pharma Dual Orexin Receptor Antagonist Sleeping Pills Product
 Table 96. Nxera Pharma Recent Developments/Updates
 Table 97. Key Raw Materials Lists
 Table 98. Raw Materials Key Suppliers Lists
 Table 99. Dual Orexin Receptor Antagonist Sleeping Pills Distributors List
 Table 100. Dual Orexin Receptor Antagonist Sleeping Pills Customers List
 Table 101. Dual Orexin Receptor Antagonist Sleeping Pills Market Trends
 Table 102. Dual Orexin Receptor Antagonist Sleeping Pills Market Drivers
 Table 103. Dual Orexin Receptor Antagonist Sleeping Pills Market Challenges
 Table 104. Dual Orexin Receptor Antagonist Sleeping Pills Market Restraints
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources
 Table 108. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dual Orexin Receptor Antagonist Sleeping Pills
 Figure 2. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Share by Type: 2024 & 2031
 Figure 4. Suvorexant Product Picture
 Figure 5. Lemborexant Product Picture
 Figure 6. Daridorexant Product Picture
 Figure 7. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value by Dosage Form, (US$ Million) & (2020-2031)
 Figure 8. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Share by Dosage Form: 2024 VS 2031
 Figure 9. Tablets Product Picture
 Figure 10. Other Product Picture
 Figure 11. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value by Research Attributes, (US$ Million) & (2020-2031)
 Figure 12. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Share by Research Attributes: 2024 VS 2031
 Figure 13. Original Drug Product Picture
 Figure 14. Generic Drug Product Picture
 Figure 15. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Value by Application (2020-2031) & (US$ Million)
 Figure 16. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Share by Application: 2024 & 2031
 Figure 17. Hospital and Clinic
 Figure 18. Retail Pharmacies
 Figure 19. Other
 Figure 20. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Size (2020-2031) & (US$ Million)
 Figure 22. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales (2020-2031) & (K Units)
 Figure 23. Global Dual Orexin Receptor Antagonist Sleeping Pills Average Price (US$/Unit) & (2020-2031)
 Figure 24. Dual Orexin Receptor Antagonist Sleeping Pills Report Years Considered
 Figure 25. Dual Orexin Receptor Antagonist Sleeping Pills Sales Share by Manufacturers in 2024
 Figure 26. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Share by Manufacturers in 2024
 Figure 27. Global 5 and 10 Largest Dual Orexin Receptor Antagonist Sleeping Pills Players: Market Share by Revenue in Dual Orexin Receptor Antagonist Sleeping Pills in 2024
 Figure 28. Dual Orexin Receptor Antagonist Sleeping Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Global Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 30. North America Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country (2020-2031)
 Figure 31. North America Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Country (2020-2031)
 Figure 32. United States Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Canada Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country (2020-2031)
 Figure 35. Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Country (2020-2031)
 Figure 36. Germany Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. France Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. U.K. Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Italy Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Russia Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Region (2020-2031)
 Figure 42. Asia Pacific Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Region (2020-2031)
 Figure 43. China Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Japan Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. South Korea Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. India Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Australia Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. China Taiwan Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Southeast Asia Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Colombia Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Country (2020-2031)
 Figure 58. Turkey Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Saudi Arabia Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. UAE Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Global Sales Market Share of Dual Orexin Receptor Antagonist Sleeping Pills by Type (2020-2031)
 Figure 62. Global Revenue Market Share of Dual Orexin Receptor Antagonist Sleeping Pills by Type (2020-2031)
 Figure 63. Global Dual Orexin Receptor Antagonist Sleeping Pills Price (US$/Unit) by Type (2020-2031)
 Figure 64. Global Sales Market Share of Dual Orexin Receptor Antagonist Sleeping Pills by Application (2020-2031)
 Figure 65. Global Revenue Market Share of Dual Orexin Receptor Antagonist Sleeping Pills by Application (2020-2031)
 Figure 66. Global Dual Orexin Receptor Antagonist Sleeping Pills Price (US$/Unit) by Application (2020-2031)
 Figure 67. Dual Orexin Receptor Antagonist Sleeping Pills Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Daridorexant Hydrochloride Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-31P19998
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Plant Derived Analgesics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35P19891
Fri Nov 14 00:00:00 UTC 2025

Add to Cart

Global Sarpogrelate Hydrochloride Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-33A16793
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions